TW201909759A - Amino acid composition for promoting muscle strength - Google Patents
Amino acid composition for promoting muscle strength Download PDFInfo
- Publication number
- TW201909759A TW201909759A TW107126222A TW107126222A TW201909759A TW 201909759 A TW201909759 A TW 201909759A TW 107126222 A TW107126222 A TW 107126222A TW 107126222 A TW107126222 A TW 107126222A TW 201909759 A TW201909759 A TW 201909759A
- Authority
- TW
- Taiwan
- Prior art keywords
- amino acid
- food
- acid composition
- muscle strength
- arginine
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 73
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 210000003205 muscle Anatomy 0.000 title claims description 56
- 230000001737 promoting effect Effects 0.000 title 1
- 235000013305 food Nutrition 0.000 claims abstract description 58
- 235000013361 beverage Nutrition 0.000 claims abstract description 29
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims abstract description 28
- 239000004475 Arginine Substances 0.000 claims abstract description 21
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 21
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims abstract description 20
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 19
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 14
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000004474 valine Substances 0.000 claims abstract description 12
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 11
- 229940127557 pharmaceutical product Drugs 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 7
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 6
- 239000004472 Lysine Substances 0.000 claims description 6
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 3
- 230000003387 muscular Effects 0.000 abstract 4
- 229940024606 amino acid Drugs 0.000 description 64
- 235000001014 amino acid Nutrition 0.000 description 64
- 229960001153 serine Drugs 0.000 description 16
- 238000012360 testing method Methods 0.000 description 15
- 235000009697 arginine Nutrition 0.000 description 14
- 229960003121 arginine Drugs 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 239000002775 capsule Substances 0.000 description 11
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- -1 amino acid salt Chemical class 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 229960004295 valine Drugs 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 102000007544 Whey Proteins Human genes 0.000 description 6
- 108010046377 Whey Proteins Proteins 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 235000015110 jellies Nutrition 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 238000004806 packaging method and process Methods 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000011632 Caseins Human genes 0.000 description 4
- 108010076119 Caseins Proteins 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 4
- 229930064664 L-arginine Natural products 0.000 description 4
- 235000014852 L-arginine Nutrition 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 235000012631 food intake Nutrition 0.000 description 4
- 239000008274 jelly Substances 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 229960002429 proline Drugs 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 239000004278 EU approved seasoning Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229930182821 L-proline Natural products 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 239000005862 Whey Substances 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000011850 desserts Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 235000021119 whey protein Nutrition 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical group OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000037147 athletic performance Effects 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 235000021438 curry Nutrition 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 235000008924 yoghurt drink Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 240000006053 Garcinia mangostana Species 0.000 description 1
- 235000017048 Garcinia mangostana Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Chemical group CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 108010070551 Meat Proteins Proteins 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Chemical group 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Chemical group 0.000 description 1
- KPQJOKRSYYJJEL-VLQRKCJKSA-K [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O Chemical compound [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O KPQJOKRSYYJJEL-VLQRKCJKSA-K 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 229940095602 acidifiers Drugs 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical group OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 150000001746 carotenes Chemical group 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- BGGQCYYULFFRLC-UHFFFAOYSA-N ethyl sulfamate Chemical compound CCOS(N)(=O)=O BGGQCYYULFFRLC-UHFFFAOYSA-N 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 235000014058 juice drink Nutrition 0.000 description 1
- 235000021581 juice product Nutrition 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 239000010699 lard oil Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000020888 liquid diet Nutrition 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 240000004308 marijuana Species 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 238000011326 mechanical measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-N methyl sulfate Chemical compound COS(O)(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 235000019412 neotame Nutrition 0.000 description 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
- 108010070257 neotame Proteins 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000012898 one-sample t-test Methods 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000004482 other powder Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000001254 oxidized starch Substances 0.000 description 1
- 235000013808 oxidized starch Nutrition 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000008519 pasta sauces Nutrition 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Chemical group CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229920006300 shrink film Polymers 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 235000013570 smoothie Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- CCXAYLQLOLXXKE-DWJAGBRCSA-K trisodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-t Chemical compound [Na+].[Na+].[Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C([O-])=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O CCXAYLQLOLXXKE-DWJAGBRCSA-K 0.000 description 1
- 229960004747 ubidecarenone Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Chemical group O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Chemical group 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Chemical group 0.000 description 1
- 150000003721 vitamin K derivatives Chemical group 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 235000021249 α-casein Nutrition 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
- 235000021247 β-casein Nutrition 0.000 description 1
- 235000021246 κ-casein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
本發明是關於一種用於提升肌力之胺基酸組合物以及包含該胺基酸組合物的食品、飲料及醫藥品。The present invention relates to an amino acid composition for enhancing muscle strength and to foods, beverages and pharmaceuticals comprising the amino acid composition.
研究了藉由攝取胺基酸組合物,提升運動機能或恢復伴隨著運動的疲勞等。 例如,在專利文獻1記載著藉由攝取包含支鏈胺基酸的飲料,提升肌肉運動機能,表示增進大鼠的自發運動量(實施例6)。專利文獻2記載著大黃蜂幼蟲所分泌的唾液中所包含的胺基酸類所構成的組合物(VAAM),做為肌力持續劑或疲勞恢復劑是有用的,可藉由老鼠強制游泳實驗等來確認效果(實施例1(1))。專利文獻3記載一種體力增強劑,其特徵在於將精胺酸做為必須成分,並由麩醯胺酸、核苷酸或核苷所成群組中選擇一種以上的成分做為有效成分來包含,以大鼠游泳運動(耗竭實驗)或比目魚肌等重量來確認效果(實施例6及7)。這些文獻只研究關於肌肉可持續運動的持續性,或未研究關於肌力。It has been studied to improve exercise function or to recover fatigue accompanying exercise by taking up an amino acid composition. For example, Patent Document 1 discloses that the muscle exercise function is enhanced by ingesting a beverage containing a branched amino acid, and the amount of spontaneous exercise of the rat is improved (Example 6). Patent Document 2 describes a composition (VAAM) composed of an amino acid contained in saliva secreted by the hornet larvae, and is useful as a muscle strength agent or a fatigue recovery agent, and can be forced to swim by a mouse or the like. The effect was confirmed (Example 1 (1)). Patent Document 3 describes a physical strength enhancer comprising arginine as an essential component, and one or more components selected from the group consisting of glutamic acid, nucleotides, or nucleosides as an active ingredient. The effects were confirmed by weights such as rat swimming exercise (depletion experiment) or soleus muscle (Examples 6 and 7). These documents only study the persistence of muscle-sustainable exercise or have not studied muscle strength.
專利文獻4記載一種肌肉增強劑,其有效成分含有鳥胺酸、瓜胺酸及精胺酸構成的胺基酸組合物,雖然確認在大鼠以肌肉增強劑促進肌蛋白質合成與增加肌肉重量(實驗例1及2),但只預測關於肌力增加(段落[0036]),沒有確認。Patent Document 4 describes a muscle reinforcing agent whose active ingredient contains an amino acid composition composed of ornithine, citrulline, and arginine, although it is confirmed that a muscle enhancer promotes muscle protein synthesis and increases muscle mass in rats ( Experimental Examples 1 and 2), but only predictions regarding muscle strength increase (paragraph [0036]), were not confirmed.
專利文獻5記載一種包含9種胺基酸的肌肉疲勞恢復促進用含胺基酸組合物,確認關於大鼠的離心收縮(Eccentric Contraction)負荷6小時後的肌力,即恢復的肌力(第七圖)。又,專利文獻6記載了以異白胺酸、白胺酸及纈胺酸為有效成分,用來抑制以類固醇治療肌力機能降低等副作用的組合物,確認抑制大鼠的握力降低(第3圖)。這些文獻企圖恢復因運動導致的肌肉損傷(專利文獻5)或抑制因疾患導致的肌力降低(專利文獻6)。 目前為止,並未研究關於用胺基酸提升肌力、特別是以健康且不疲勞狀態為基準的肌力提升。 [先前技術文獻] [專利文獻]Patent Document 5 describes an amino acid-containing composition for muscle fatigue recovery promotion comprising nine kinds of amino acids, and confirms the muscle strength after the eccentric contraction load of the rat for 6 hours, that is, the restored muscle strength (No. Seven figures). Further, Patent Document 6 describes a composition for inhibiting side effects such as reduction in muscle function by steroid using aspartic acid, leucine, and valine as an active ingredient, and confirms that the grip strength of the rat is suppressed (third) Figure). These documents attempt to restore muscle damage caused by exercise (Patent Document 5) or to suppress a decrease in muscle strength due to a disease (Patent Document 6). So far, no research has been conducted on the improvement of muscle strength with amino acid, especially on the basis of healthy and non-fatigue state. [Prior Technical Literature] [Patent Literature]
[專利文獻1]特開昭58-165774號公報 [專利文獻2]特許第2518692號公報 [專利文獻3]特開平9-124473號公報 [專利文獻4]國際公開第2015/137387號 [專利文獻5]國際公開第2013/021591號 [專利文獻6]國際公開第2008/072663號[Patent Document 1] Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. 5] International Publication No. 2013/021591 [Patent Document 6] International Publication No. 2008/072663
[發明所欲解決的問題] 因此,本發明的問題在於提供一種胺基酸組合物,具有全新用途,即在以往未研究,使以健康且不疲勞的狀態為基準的肌力提升。 [解決問題的手段][Problems to be Solved by the Invention] Accordingly, an object of the present invention is to provide an amino acid composition which has a novel use, that is, has not been studied in the past, and has improved muscle strength based on a state of being healthy and not fatigued. [Means for solving problems]
本案發明人為了解決前述問題,在努力研究中,專注於精胺酸、纈胺酸及絲胺酸,在僅包含這三個胺基酸的胺基酸組合物發現高肌力提升效果,進一步進行研究的結果,完成了本發明。In order to solve the aforementioned problems, the inventors of the present invention focused on arginine, lysine, and serine in an effort to find a high muscle strength improving effect in an amino acid composition containing only these three amino acids. As a result of conducting the research, the present invention has been completed.
也就是說,本發明是關於以下發明。 [1]一種用於提升肌力之胺基酸組合物,是由精胺酸、纈胺酸及絲胺酸所構成。 [2]前述[1]所述的胺基酸組合物,其中精胺酸、纈胺酸及絲胺酸的重量比為50~70:25~50:0.1~15。 [3]前述[1]所述的胺基酸組合物,其中精胺酸、纈胺酸及絲胺酸的重量比為10~28:7~22:1。 [4]前述[1]~[3]中任一項所述的胺基酸組合物,是裝在可食用容器而成。 [5]一種用於提升肌力的食品、飲料或醫藥品,包含有效量的前述[1]~[4]中任一項所述的胺基酸組合物。 [6]前述[5]所述的食品、飲料或醫藥品,包含非有效量的精胺酸、纈胺酸及絲胺酸以外的胺基酸。 [7]前述[5]或[6]所述的食品、飲料或醫藥品,更包含非胺基酸的用於提升肌力的有效成分。 [8]前述[5]~[7]中任一項所述的食品、飲料或醫藥品,是裝在容器而成。 [9]一種如前述[1]~[4]中任一項所述的胺基酸組合物或前述[5]~[8]中任一項所述的食品、飲料或醫藥品的製造方法,包含:混合精胺酸、纈胺酸及絲胺酸。 [發明效果]That is, the present invention relates to the following invention. [1] An amino acid composition for improving muscle strength, which is composed of arginine, valine and serine. [2] The amino acid composition according to the above [1], wherein the weight ratio of arginine, valine and serine is from 50 to 70:25 to 50:0.1 to 15. [3] The amino acid composition according to the above [1], wherein the weight ratio of arginine, valine and serine is from 10 to 28:7 to 22:1. [4] The amino acid composition according to any one of [1] to [3] above which is contained in an edible container. [5] A food, a beverage, or a pharmaceutical composition for improving muscle strength, comprising an effective amount of the amino acid composition according to any one of the above [1] to [4]. [6] The food, drink or pharmaceutical according to the above [5], which comprises a non-effective amount of an amino acid other than arginine, proline or serine. [7] The food, drink or pharmaceutical according to the above [5] or [6], which further comprises an active ingredient for improving muscle strength of a non-amino acid. [8] The food, drink or pharmaceutical according to any one of the above [5] to [7], which is contained in a container. The method for producing a food, beverage, or pharmaceutical according to any one of the above [1] to [4], wherein the food, beverage, or pharmaceutical product according to any one of the above [5] to [8] Contains: mixed arginine, valine and serine. [Effect of the invention]
根據本發明可提供一種可提升肌力,特別是提升以健康且不疲勞狀態為基準的肌力的胺基酸組合物,包含該胺基酸組合物的食品、飲料以及醫藥品。特別是,根據本發明,瞬間肌力提升,肌力力學測量值(例如握力或腿伸展肌力等)增加,運動表現提升。According to the present invention, there is provided an amino acid composition which can improve muscle strength, particularly muscle strength based on a healthy and non-fatigue state, a food, a drink, and a pharmaceutical containing the amino acid composition. In particular, according to the present invention, the instantaneous muscle strength is increased, the muscle force mechanical measurement value (for example, the grip strength or the leg stretching muscle strength, etc.) is increased, and the exercise performance is improved.
本發明的用於提升肌力之胺基酸組合物,是由精胺酸、纈胺酸及絲胺酸之三種類所構成。精胺酸、纈胺酸及絲胺酸的重量比,在一態樣中為50~70:25~50:0.1~15,在其他態樣中,為10~28:7~22:1,較佳為15~18:11~14:1。藉由做為如此重量比,更進一步達成肌力提升效果。The amino acid composition for improving muscle strength of the present invention is composed of three types of arginine, lysine and serine. The weight ratio of arginine, valine and serine is 50 to 70:25 to 50:0.1 to 15 in one aspect, and 10 to 28:7 to 22:1 in other aspects. It is preferably 15 to 18:11 to 14:1. By doing this weight ratio, the muscle strength improvement effect is further achieved.
本發明的胺基酸組合物,在一態樣中,裝在容器中,較佳為裝在可食用容器。可食用容器是指列舉製劑用膠囊等。藉由使用可食用容器,裝在容器中的胺基酸組合物可以直接添加於食品、飲料、醫藥品中。The amino acid composition of the present invention, in one aspect, is contained in a container, preferably in an edible container. The edible container refers to a capsule for formulation and the like. The amino acid composition contained in the container can be directly added to foods, beverages, and pharmaceuticals by using an edible container.
本發明的胺基酸組合物要達成肌力提升效果,可以有效量添加於食品、飲料或醫藥品來使用。添加有有效量的胺基酸組合物的食品或飲料,成為與自然界直接存在的食品或飲料不同的組成。像這樣的有效量雖然可由本領域人士適當決定,但例如精胺酸、纈胺酸及絲胺酸的總重量為500mg~10000mg,較佳為1500mg~5000mg,特佳為2500mg~3500mg。The amino acid composition of the present invention has an effect of improving muscle strength, and can be used in an effective amount in a food, a drink or a pharmaceutical. A food or beverage to which an effective amount of an amino acid composition is added becomes a composition different from a food or beverage directly existing in nature. The effective amount as such may be appropriately determined by those skilled in the art, for example, the total weight of arginine, valine and serine is from 500 mg to 10,000 mg, preferably from 1500 mg to 5000 mg, particularly preferably from 2500 mg to 3500 mg.
本發明的食品、飲料或醫藥品,也可以包含精胺酸、纈胺酸及絲胺酸以外的胺基酸。 在本發明中,精胺酸、纈胺酸及絲胺酸以外的胺基酸,若是已知能用於提升肌力,也可以包含例如對達成肌力提升效果並非有效的量(非有效量)。像這樣的非有效量可由本領域人士適當決定。The food, drink or pharmaceutical of the present invention may also contain an amino acid other than arginine, lysine or serine. In the present invention, an amino acid other than arginine, lysine, and serine may be used to increase muscle strength, and may also contain, for example, an amount that is not effective for achieving a muscle-boosting effect (non-effective amount). . An ineffective amount like this can be appropriately determined by those skilled in the art.
用於本發明的胺基酸也可以分別使用L-體、D-體、DL-體中的任一種,較佳為為L-體、DL-體,更佳為L-體。又,用於本發明的胺基酸不僅各為游離體,也可以使用胺基酸鹽。胺基酸鹽若是可容許做為食品、飲料或醫藥品的胺基酸鹽,則沒有特別限制,舉出例如胺基酸的酸加成鹽或與鹼基的鹽等。The amino acid used in the present invention may also be any one of an L-form, a D-form, and a DL-form, and is preferably an L-form, a DL-form, or more preferably an L-form. Further, the amino acids used in the present invention may each be not only a free form but also an amino acid salt. The amino acid salt is not particularly limited as long as it is an amino acid salt which can be tolerated as a food, a drink or a pharmaceutical, and examples thereof include an acid addition salt of an amino acid or a salt with a base.
關於可容許做為用於本發明的胺基酸的食品的鹽,做為形成該鹽的酸,舉出例如鹽酸、溴化氫、硫酸、磷酸等無機酸;乙酸、乳酸、檸檬酸、酒石酸、馬來酸、富馬酸、單甲基硫酸等有機酸等。又,可容許做為食品的鹽的鹼基,舉出例如鈉、鉀、鈣、氨等無機鹼或乙二胺、丙二胺、乙醇胺、單烷基乙醇胺、二烷基乙醇胺、二乙醇胺、三乙醇胺等有機鹼基。 用於本發明的胺基酸鹽也可以是水合物(水合鹽),做為像這樣的水合物,舉出例如1~6水合物。As the salt of the food which can be tolerated as the amino acid used in the present invention, as the acid forming the salt, for example, inorganic acids such as hydrochloric acid, hydrogen bromide, sulfuric acid, phosphoric acid, etc.; acetic acid, lactic acid, citric acid, tartaric acid , organic acids such as maleic acid, fumaric acid, and monomethyl sulfuric acid. Further, examples of the base which can be used as a salt of a food include an inorganic base such as sodium, potassium, calcium or ammonia, or ethylenediamine, propylenediamine, ethanolamine, monoalkylethanolamine, dialkylethanolamine or diethanolamine. Organic bases such as triethanolamine. The amino acid salt used in the present invention may also be a hydrate (hydrated salt), and as such a hydrate, for example, a hydrate of 1 to 6 is exemplified.
用於本發明的胺基酸,也可以使用藉由從含有這些的動植物、微生物萃取精製者,或以化學合成法、發酵法、基因重組法所獲得的任一者。又,也可以市售產品。 用於本發明的胺基酸較佳為分別使用單獨高純度者。例如,使用「日本食品添加物公定書」所規定的純度以上的胺基酸。又,也可以使用其生理學上可容許的鹽的形態者做為這些胺基酸。The amino acid used in the present invention may be any one obtained by extracting and purifying animals, plants, microorganisms containing these, or by chemical synthesis, fermentation, or genetic recombination. Also, it is also commercially available. The amino acid used in the present invention is preferably one which is used alone in high purity. For example, an amino acid having a purity equal to or higher than that specified in the "Japanese Food Additives" is used. Further, those having a physiologically acceptable salt can also be used as these amino acids.
在製造本發明的胺基酸組合物時,也可以混合上述胺基酸。又,在製造溶液時,也可以將此與蒸餾水、乙醇等混合溶解。 本發明的食品、飲料或醫藥品也可以更包含非胺基酸的用於肌力提升的有效成分。做為像這樣的有效成分,舉出例如蛋白質或維他命D等。In the production of the amino acid composition of the present invention, the above amino acid may also be mixed. Further, when the solution is produced, it may be mixed and dissolved with distilled water, ethanol or the like. The food, drink or pharmaceutical of the present invention may further comprise an active ingredient for muscle strength enhancement of a non-amino acid. As such an active ingredient, for example, protein or vitamin D is mentioned.
做為可包含在本發明的食品、飲料或醫藥品中的成分,若可攝取(投藥)至體內,則沒有特別限制,但通常是與醫藥品及/或飲料食品混合的成分,可配合例如維生素B1、維生素B2、維生素B6、泛酸等維生素,輔酶Q10、肉毒鹼、α-硫辛酸等維生素類物質,鐵、鋅等礦物質類,葡萄糖、果糖、半乳糖、甘露糖、蔗糖、麥芽糖、乳糖等醣類,檸檬酸、酒石酸、抗壞血酸、蘋果酸、醋酸、草酸、磷酸、乳酸、丁酸、琥珀酸、富馬酸及葡萄糖酸等有機酸,咖啡因、可可鹼、茶胺酸、兒茶素等多酚類等。The ingredient which can be contained in the food, drink or pharmaceutical of the present invention is not particularly limited as long as it can be ingested (administered) into the body, but is usually a component mixed with a pharmaceutical product and/or a food or drink, and can be blended, for example. Vitamin B1, vitamin B2, vitamin B6, pantothenic acid and other vitamins, coenzyme Q10, carnitine, alpha-lipoic acid and other vitamins, iron, zinc and other minerals, glucose, fructose, galactose, mannose, sucrose, maltose , sugars such as lactose, organic acids such as citric acid, tartaric acid, ascorbic acid, malic acid, acetic acid, oxalic acid, phosphoric acid, lactic acid, butyric acid, succinic acid, fumaric acid and gluconic acid, caffeine, theobromine, theanine, Polyphenols such as catechins.
又,可混合例如麩酸鈉、牛磺酸等胺基酸成分,蔗糖素、紐甜、乙醯磺胺酸鉀、索馬甜、甜菊萃取物、甘草萃取物、羅漢果萃取物、糖精、糖精鈉、甘草酸、甘草酸二鈉、甘草酸三鈉、二氫查耳酮、甜菊糖、甜菊糖雙A等甜味劑,鋅、硒、鐵、銅等礦物質,海藻糖、低聚醣、稀有糖等糖類,乳酸菌、雙叉乳酸桿菌、丙酸桿菌等有用的微生物或其培養物,蜂王漿、膠原蛋白、腦醯胺、葡萄糖胺、還原蝦紅素、多酚等既存的功能性材料,香料、pH調節劑、賦形劑、檸檬酸等酸味劑,著色劑、乳化劑、防腐劑等。Further, an amino acid component such as sodium glutamate or taurine, sucralose, neotame, ethyl sulfamate, thaumatin, stevia extract, licorice extract, mangosteen extract, saccharin, sodium saccharin, and the like may be mixed. Sweeteners such as glycyrrhizic acid, disodium glycyrrhizinate, trisodium glycyrrhizinate, dihydrochalcone, stevioside, stevioside A, minerals such as zinc, selenium, iron, copper, trehalose, oligosaccharides, rare Sugars such as sugar, lactic acid bacteria, Lactobacillus brevis, Propionibacterium, and other useful microorganisms or cultures thereof, and existing functional materials such as royal jelly, collagen, ceramide, glucosamine, reduced astaxanthin, polyphenols, and the like. , pH adjusters, excipients, acidifiers such as citric acid, colorants, emulsifiers, preservatives, and the like.
做為本發明的胺基酸組合物的攝取(投藥)形態,若可攝取(投藥)至體內,則其方法沒有限制,但較佳為以錠劑、包衣錠劑、膠囊劑、顆粒劑、粉劑、溶液、糖漿劑、乳劑等進行口服投藥。這些各種製劑根據常規方法,在賦形劑、黏合劑、崩解劑、潤滑劑、著色劑、矯味劑、增溶劑、懸浮劑、塗料劑等醫藥製劑領域,可以使用通常使用的已知助劑於本發明的胺基酸組合物來製劑化。The method for ingesting (administering) the amino acid composition of the present invention is not limited as long as it can be ingested (administered) into the body, but is preferably a tablet, a coated tablet, a capsule, or a granule. , powder, solution, syrup, emulsion, etc. are administered orally. These various preparations can be used in the field of pharmaceutical preparations such as excipients, binders, disintegrants, lubricants, coloring agents, flavoring agents, solubilizing agents, suspending agents, coating agents, etc. according to a conventional method, and conventionally used auxiliary agents can be used. Formulated in the amino acid composition of the present invention.
本發明的飲料食品在一態樣中也可以提供例如加入飲料食品用素材及食品添加物等,來做為飲料食品(包含特定保健用食品、機能性表示食品、營養機能食品等保健機能食品、營養輔助食品、其他健康食品、補給品)。In one aspect, the beverage food of the present invention may be used as a food and beverage (including a health food, a functional food, a nutritious food, and the like, and may be provided as a food and drink, etc.). Nutritional supplements, other health foods, supplements).
本發明的飲料食品可做為例如飲料、酸乳飲料等乳製品、果凍狀產品、冰淇淋類、冰品、餅乾、口膠狀產品、粉狀產品、顆粒狀產品、片狀產品、膠囊狀產品、錠狀產品、糖果的固體狀的加工食品等。The beverage food of the present invention can be used as a dairy product such as a beverage or a yogurt drink, a jelly product, an ice cream, an ice product, a biscuit, a mouth gel product, a powder product, a granulated product, a sheet product, a capsule product. , solid products such as ingot products, candy, etc.
本發明的飲料食品是指醫藥組合物以外者,若為溶液、懸浮液、乳化液、粉末、固體成形物等,可經口攝取的形態即可,沒有特別的限制。具體來說,舉出例如乳飲料、酸乳飲料類、乳酸菌飲料、發酵乳、冰淇淋類、奶油類、乳酪類等乳製品;清涼飲料、果汁飲料、蔬菜飲料、豆奶飲料、咖啡飲料、茶飲料、果凍飲料、可可、冰沙等粉末飲料或和運動粉末飲料、營養強化粉末飲料、粉末食品、粉末湯、饅頭、濃縮飲料、酒精飲料等飲料類;麵包、義大利麵、麵條、蛋糕粉、炸粉、麵包粉等小麥粉產品;巧克力、口香糖、糖果、餅乾、軟糖、點心、日式甜點、果凍、布丁等西點甜點等甜點類;加工調味料、風味調味料、綜合調味品等調味料;咖哩、義大利麵醬、火上鍋、燉菜、日式食品的殺菌袋裝食品;加工油脂、黃油、人造黃油、塗抹料、美乃滋等油脂類;冷凍乾燥食品等速食食品;農業罐頭、果醬、果皮醬類、熟豆、榖類食品、菜粥等農產加工品;水產加工品;畜產加工品;比薩、焗飯、奶油烤通心粉、家常菜、炸物等冷凍食品;流質飲食、增稠調整食品、還有動物飼料、錠劑等。The food or drink of the present invention is not particularly limited as long as it is a solution, a suspension, an emulsion, a powder, a solid molded product, or the like, which can be orally ingested. Specifically, for example, dairy products such as milk beverages, yogurt drinks, lactic acid bacteria beverages, fermented milk, ice creams, creams, and cheeses; refreshing drinks, juice drinks, vegetable drinks, soy milk drinks, coffee drinks, and tea drinks are mentioned. , jelly drinks, cocoa, smoothies and other powder drinks or sports powder drinks, nutritionally enhanced powder drinks, powdered foods, powder soups, taro, concentrated drinks, alcoholic beverages, etc.; bread, pasta, noodles, cake powder, Wheat flour products such as fried flour and bread flour; desserts such as chocolate, chewing gum, candy, biscuits, soft candy, snacks, Japanese desserts, jellies, puddings, etc.; desserts such as processed seasonings, flavor seasonings, and comprehensive seasonings; Curry, curry, pasta sauce, fire pot, stew, Japanese food, sterilized bagged food; processed oils, butter, margarine, spreads, cannabis and other oils; freeze-dried foods and other fast-food foods; Agricultural canned food, jam, peel sauce, cooked beans, oysters, vegetable porridge and other agricultural products; aquatic products; processed products; Baked rice, frozen food macaroni gratin, home cooking, frying and the like; liquid diet, food thickening adjustment, as well as animal feed, troches and the like.
當使用本發明的胺基酸組合物於飲料食品時,對於其他成分並沒有特別限定,但前述飲料食品可使用水、蛋白質、碳水化合物、脂質、維生素類、礦物質類、有機酸、有機鹼、果汁、調味劑類等做為成分。蛋白質舉出例如全脂奶粉、脫脂奶粉、部分脫脂奶粉、酪蛋白、乳清粉、乳清蛋白、乳清蛋白濃縮物、乳清蛋白分離物、α-酪蛋白、β-酪蛋白、,kappa-酪蛋白、β-乳球蛋白、α-乳清蛋白、乳鐵蛋白、大豆蛋白質、卵蛋白質、肉蛋白質、這些的水解產物;黃油、乳清礦物質、奶油、乳清、非蛋白氮、唾液酸、磷脂、乳糖等各種乳來源成分等。碳水化合物舉出醣類、加工澱粉(除了糊精,還有可溶性澱粉、英國澱粉、氧化澱粉、澱粉酯、澱粉醚等),膳食纖維等。做為脂質,舉出例如豬油、魚油等、這些的分餾油、氫化油、酯交換油等動物脂肪;棕櫚油、紅花油、玉米油、菜仔油、椰子油、這些的分餾油、氫化油、酯交換油等植物油。做為維生素,舉出例如維生素A、胡蘿蔔素類、維生素B群、維生素C、維生素D群、維生素E、維生素K群、維生素P、維生素Q、菸鹼酸、泛酸、生物素、肌醇、膽鹼,葉酸等,做為礦物質類,舉出例如鈣、鉀、鎂、鈉、銅、鐵、錳、鋅、硒等。做為有機酸,舉出例如蘋果酸、檸檬酸、乳酸、酒石酸等。這些成分,可組合兩種以上使用,也可以使用包含許多合成品及/或這些的食品。When the amino acid composition of the present invention is used in a food or drink, the other ingredients are not particularly limited, but the aforementioned foods and drinks may use water, protein, carbohydrates, lipids, vitamins, minerals, organic acids, and organic bases. Juices, flavorings, etc. are used as ingredients. The protein is exemplified by whole milk powder, skimmed milk powder, partially skimmed milk powder, casein, whey powder, whey protein, whey protein concentrate, whey protein isolate, α-casein, β-casein, kappa - casein, beta-lactoglobulin, alpha-lactalbumin, lactoferrin, soy protein, egg protein, meat protein, hydrolysates of these; butter, whey minerals, butter, whey, non-protein nitrogen, Various milk-derived components such as sialic acid, phospholipids, and lactose. Carbohydrates include sugars, processed starches (except dextrin, soluble starch, British starch, oxidized starch, starch esters, starch ethers, etc.), dietary fiber, and the like. As the lipid, for example, lard oil, fish oil, and the like, animal fat such as fractionated oil, hydrogenated oil, and transesterified oil; palm oil, safflower oil, corn oil, rapeseed oil, coconut oil, fractionated oil of these, hydrogenation Vegetable oils such as oil and transesterified oil. As vitamins, for example, vitamin A, carotene, vitamin B group, vitamin C, vitamin D group, vitamin E, vitamin K group, vitamin P, vitamin Q, nicotinic acid, pantothenic acid, biotin, inositol, Choline, folic acid, etc., as minerals, for example, calcium, potassium, magnesium, sodium, copper, iron, manganese, zinc, selenium, and the like. As the organic acid, for example, malic acid, citric acid, lactic acid, tartaric acid or the like is mentioned. These components may be used in combination of two or more kinds, and foods containing many synthetic products and/or these may also be used.
本發明的食品、飲料、醫藥品在一態樣中,可以裝在容器,該容器也可以選自塑膠製、紙製、金屬製、陶瓷製或其複合材料等。可做為裝在這些容器的裝入容器形態。也就是說,可例示含有本發明的胺基酸組合物的裝入容器的飲料食品、裝入容器的醫藥品。又,也可以用塑膠製的收縮膜、遮光膜(例如金屬箔層膜、黑色或深色油墨塗佈膜)來被覆容器,也可以組合兩種以上的前述容器或前述膜來使用。從風味劣化及分解(減少)的觀點來看,組合有遮光性的容器或膜為較佳。The food, the beverage, and the pharmaceutical product of the present invention may be contained in a container, and the container may be selected from the group consisting of plastic, paper, metal, ceramic, or composite materials thereof. It can be used as a loading container in these containers. That is, a food and beverage packaged in a container containing the amino acid composition of the present invention, and a pharmaceutical product filled in the container can be exemplified. Further, the container may be coated with a shrink film made of plastic, a light-shielding film (for example, a metal foil film, a black or dark ink coating film), or two or more types of the container or the film may be used in combination. From the viewpoint of deterioration of flavor and decomposition (reduction), a container or film having a light-shielding property is preferable.
本發明的胺基酸組合物或飲料食品,由每餐的單位包裝形態構成,在該單位包裝形態中,包含精胺酸、纈胺酸及絲胺酸。在此,「每餐的單位包裝形態」是指預先決定每餐的攝取量的形態者,例如做為可以口服攝取特定量的飲料食物,不僅是一般食品,也指飲料(如飲料劑等)、健康輔助食品、保健機能食品、補給品等。在「每餐的單位包裝形態」中,舉出例如在液狀飲料、凝膠狀、糊狀或糊狀果凍、粉末狀、顆粒狀、膠囊狀或塊狀固體食品等的情況下,是以金屬罐、玻璃瓶(瓶罐等)、塑膠容器(PET瓶等)、包裝、袋、膜容器、紙箱等包裝容器來規定特定量(用量)的形態,或者是可藉由將每餐的攝取量(用法、用量)表示在包裝容器或網頁等來規定特定量的形態。The amino acid composition or the food or beverage of the present invention is composed of a unit package form per meal, and includes arginine, lysine, and serine in the unit package form. Here, the "unit packaging form per meal" refers to a form in which the amount of intake per meal is determined in advance, for example, as a foodstuff that can be orally ingested in a specific amount, not only a general food but also a beverage (such as a beverage). , health supplement foods, health functional foods, supplies, etc. In the case of "unit packaging form per meal", for example, in the case of a liquid beverage, a gel, a paste or a paste jelly, a powder, a granule, a capsule, or a solid food, Packaging containers such as metal cans, glass bottles (bottles, etc.), plastic containers (PET bottles, etc.), packaging, bags, film containers, cartons, etc., to specify a specific amount (amount), or by ingesting each meal The amount (usage, amount) indicates a form in which a specific amount is specified in a packaging container or a web page.
本發明的胺基酸組合物或飲料食品的每日攝取量,是根據運動、年齡、性別、體重、飲食狀況等來個別決定。 本發明的胺基酸組合物、含有其之食品、飲料或醫藥品,藉由提升肌力,可期待運動表現提升,所以較佳使用於沒有運動習慣的人、業餘運動員、專業運動員、潛在肥胖者、肥胖者、代謝綜合症患者或動物,競賽用動物等。The daily intake of the amino acid composition or the food or beverage of the present invention is determined individually according to exercise, age, sex, body weight, eating condition, and the like. The amino acid composition of the present invention, the food, the beverage or the pharmaceutical product containing the same can be expected to improve the exercise performance by improving the muscle strength, so it is preferably used for people who do not have exercise habits, amateur athletes, professional athletes, and potential obesity. , obese, metabolic syndrome patients or animals, competition animals, etc.
本發明的胺基酸組合物或飲料食品,賦予標示來表示有效提升肌力予運動表現,較佳為可期待肌力提升、瞬發力提升、運動表現提升,所以也可以賦予標示來表示例如可發揮高肌力、可發揮理想的表現、輕鬆移動、有效超越以往表現極限等。The amino acid composition or the food or beverage of the present invention is labeled to express effective muscle strength to exercise performance, and it is preferable to increase muscle strength, increase instantaneous force, and improve exercise performance, so that a mark can be given to indicate, for example. It can exert high muscle strength, can achieve ideal performance, move easily, and effectively exceed the performance limits of the past.
在此,本發明的標示若為關於用於提升肌力的胺基酸組合物,則沒有特別限制,也可以賦予組合物是有效的標示、廣告等在例如含有用於提升肌力的胺基酸組合物、食品、飲料、醫藥品的容器、包裝材料或說明書。又,本發明的標示也可以是賦予組合物是有效的標示、廣告等在例如傳單、小冊子、廣告物、目錄、海報、書籍、DVD等記錄媒體、電子佈告欄或網際網路等的廣告。再者,類似於本發明的標示的內容,以協商及/或促進販賣為目的,可以經由口頭及/或錄音錄影的記錄媒體來重現,傳達給第三方。Here, the labeling of the present invention is not particularly limited as long as it relates to an amino acid composition for improving muscle strength, and the composition may be effectively labeled, advertised, etc., for example, containing an amine group for enhancing muscle strength. Acid composition, food, beverage, pharmaceutical container, packaging material or instructions. Further, the label of the present invention may be an advertisement for giving the composition an effective label, an advertisement or the like on a recording medium such as a leaflet, a booklet, an advertisement, a catalog, a poster, a book, a DVD, an electronic bulletin board, or the Internet. Furthermore, the content of the logo similar to the present invention may be reproduced and communicated to a third party via a verbal and/or recorded recording medium for the purpose of negotiating and/or facilitating the sale.
在製造本發明的用於提升肌力的胺基酸組合物、食品、飲料、醫藥品時,也可以使用上述胺基酸,將這些混合。又,做為飲料時,也可以將這些與蒸餾水等混合溶解。 [實施例]When the amino acid composition for improving muscle strength of the present invention, a food, a drink, or a pharmaceutical is produced, these amino acids may be used and these may be mixed. Further, when used as a beverage, these may be mixed and dissolved in distilled water or the like. [Examples]
以下,雖然表示實施例,來更具體地說明本發明,但本發明的範圍並非受限於這些實施例的記載。Hereinafter, the present invention will be more specifically described by showing examples, but the scope of the invention is not limited by the description of the examples.
例1:胺基酸組合物的製備(放入膠囊) 將L-精胺酸、L-纈胺酸及L-絲胺酸充填至Cellulose White Capsule00號(Matsuya Co., Ltd製造),製備膠囊化胺基酸組合物(實施例1),使得L-精胺酸1800mg、L-纈胺酸1100mg及L-絲胺酸100mg。此外,L-精胺酸、L-纈胺酸及L-絲胺酸是Kyowa Hakko Bio Co., Ltd製造。Example 1: Preparation of Amino Acid Composition (Into Capsule) L-arginine, L-proline, and L-serine were filled into Cellulose White Capsule No. 00 (manufactured by Matsuya Co., Ltd.) to prepare a capsule. The amino acid composition (Example 1) was made to have 1800 mg of L-arginine, 1100 mg of L-proline, and 100 mg of L-serine. Further, L-arginine, L-valine and L-serine are manufactured by Kyowa Hakko Bio Co., Ltd.
例2:肌力測量實驗 測量攝取本發明的胺基酸組合物時的肌力。測試系統的概要表示在第1圖。 做為測試食品,使用受試食品(實施例1的放入膠囊的胺基酸組合物)及對照食品(為了從外觀無法辨識,並維持雙盲試驗性,在與受試食品一樣的Cellulose White Capsule00號5粒(Matsuya Co., Ltd製造)使用加入糊精3000mg者(比較例1))。Example 2: Muscle strength measurement experiment The muscle strength at the time of ingesting the amino acid composition of the present invention was measured. A summary of the test system is shown in Figure 1. As a test food, the test food (the encapsulated amino acid composition of Example 1) and the control food (in order to be unrecognizable from the appearance and maintain double-blind testability, in the same Cellulose White as the test food) Capsule No. 5 (manufactured by Matsuya Co., Ltd.) was added to a dextrin 3000 mg (Comparative Example 1).
將受試者(20歲及以上的健康人(男性19人))隨機分為兩群,以篩選時的年齡、體重做為指標,並進行雙盲交叉比較試驗。 第1群(9人),首先進行受試食品攝取測試,之後以6天以上間隔,進行對照食物攝取測試,第2群(10人)預先進行對照食物攝取測試,之後以6天以上間隔,進行受測食物攝取測試。The subjects (healthy persons aged 20 years and older (19 males)) were randomly divided into two groups, and the age and body weight at the time of screening were used as indicators, and a double-blind cross-comparison test was performed. In the first group (9 persons), the test food intake test was first performed, and then the control food intake test was performed at intervals of 6 days or longer, and the second group (10 persons) was subjected to the control food intake test in advance, and then at intervals of 6 days or more. Conduct a food intake test.
測試食品是在肌力測量前2天及前1天攝取3000mg2次,在肌力測量當天攝取一次。在肌力測量的前1天的晚餐是指定飲食,中間有12.5~15.5小時的禁食時間,測量肌力當天攝取醣類果凍。攝取醣類果凍1小時後,攝取測試食品,並在攝取測試食品10分後以自行車測力計(Aero Bike(註冊商標)75XLIII(Konami Sports Life Co., Ltd製造)進行熱身,攝攝取測試食品30分後實施肌力測量。The test food was taken twice a day and 2 days before the measurement of muscle strength, and once a day on the day of muscle strength measurement. The dinner on the first day of the muscle strength measurement is the designated diet, with a fasting period of 12.5 to 15.5 hours in the middle, and the measurement of muscle strength on the day of intake of sugar jelly. After taking the icing sugar for 1 hour, the test food was ingested, and after taking the test food for 10 minutes, the bicycle was measured by a bicycle dynamometer (Aero Bike (registered trademark) 75XLIII (manufactured by Konami Sports Life Co., Ltd.), and the test food was taken. The muscle strength measurement was performed after 30 minutes.
肌力測量是測量握力和等速性腿伸展肌力。 握力是以數位握力計「GRIP D」(Takei Instrumentation Industry Co., Ltd製造)測量雙手,計算雙手握力的平均值。等速性腿伸展肌力是以「LEG POWER」(由Takei Instrumentation Industry Co.,Ltd。製造),測量當彎曲的雙腿一口氣伸展時發揮的肌力。連續三次測量等速性腿伸展肌力,採用最大值。 使用對應的單樣本t檢驗來檢定平均值的差。顯著水準設為5%。Muscle force measurement is the measurement of grip strength and constant-speed leg extension muscle strength. The grip strength was measured by a digital grip meter "GRIP D" (manufactured by Takei Instrumentation Industry Co., Ltd.), and the average value of the grip strength of both hands was calculated. The constant-speed leg stretching muscle strength was measured by "LEG POWER" (manufactured by Takei Instrumentation Industry Co., Ltd.) to measure the muscle strength when the curved legs were stretched in one breath. The isometric leg stretching muscle strength was measured three times in succession, using the maximum value. The corresponding one-sample t-test was used to verify the difference in the mean. The level of significance is set to 5%.
握力的測量結果表示在第2圖,等速性腿伸展肌力的測量結果表示在第3圖。 當攝取實施例1時,與攝取比較例1相比,握力及等速性腿伸展肌力兩者皆提升。此結果表示,本發明的胺基酸組合物提升肌力,特別是以健康且不疲勞狀態為基準的肌力,手腳皆提升。The measurement result of the grip strength is shown in Fig. 2, and the measurement result of the isometric leg extension muscle strength is shown in Fig. 3. When Example 1 was ingested, both the grip strength and the constant-speed leg stretching muscle strength were improved as compared with the ingestion of Comparative Example 1. This result indicates that the amino acid composition of the present invention enhances muscle strength, particularly muscle strength based on a healthy and non-fatigue state, and both hands and feet are elevated.
例3:胺基酸組合物的保存性 將L-精胺酸1800mg、L-纈胺酸1100mg及L-絲胺酸100mg填充到Cellulose White Capsule00號,製造加入膠囊的胺基酸組合物,填充至鋁袋容器。在室溫下儲存2週後,膠囊內的含有胺基酸的組合物保持不分解(減少)。 [產業利用性]Example 3: Preservability of Amino Acid Composition The 1800 mg of L-arginine, 1100 mg of L-proline, and 100 mg of L-serine were filled into Cellulose White Capsule No. 00 to prepare a capsule-containing amino acid composition, and filled. To the aluminum bag container. After storage for 2 weeks at room temperature, the amino acid-containing composition in the capsule remained undecomposed (reduced). [Industry Utilization]
本發明的胺基酸組合物藉由運動開始時的提升肌力效果,可提升運動表現或對運動的動機。藉此,可設計用來維持、提升運動量少的人習慣實施運動的可能性,或是業餘運動員或專業運動員的運動表現。此時,有助於延長日本人的健康壽命,結果,因降低醫療費等,可對社會有莫大貢獻。The amino acid composition of the present invention enhances athletic performance or motivation for exercise by enhancing the muscle strength at the beginning of exercise. In this way, it can be designed to maintain and enhance the possibility that people with less exercise are accustomed to exercise, or the athletic performance of amateur athletes or professional athletes. At this time, it helps to prolong the healthy life of the Japanese. As a result, it can contribute to society by reducing medical expenses.
無。no.
第1圖表示測試系統的概要的說明圖。 第2圖表示分別攝取實施例1與比較例1的情況下的握力的測量結果的圖。 第3圖表示分別攝取實施例1與比較例1的情況下的等速性腿伸展肌力的測量結果的圖。Fig. 1 is an explanatory diagram showing an outline of a test system. Fig. 2 is a view showing measurement results of grip strength in the case of ingesting Example 1 and Comparative Example 1, respectively. Fig. 3 is a graph showing the measurement results of the isosceles leg muscle strength in the case of ingesting Example 1 and Comparative Example 1, respectively.
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017-146545 | 2017-07-28 | ||
JP2017146545A JP2019024389A (en) | 2017-07-28 | 2017-07-28 | Amino acid composition for improved muscle strength |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201909759A true TW201909759A (en) | 2019-03-16 |
Family
ID=65039591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW107126222A TW201909759A (en) | 2017-07-28 | 2018-07-27 | Amino acid composition for promoting muscle strength |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2019024389A (en) |
TW (1) | TW201909759A (en) |
WO (1) | WO2019022216A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58165774A (en) * | 1982-03-29 | 1983-09-30 | Ajinomoto Co Inc | Drink composition |
BRPI0311909A8 (en) * | 2002-06-19 | 2018-02-06 | Nutricia Nv | METHODS FOR MANUFACTURING A COMPOSITION, AND FOR INCREASE THE METHYLATION CAPACITY OF A SUBJECT, AND, PHARMACEUTICAL OR NUTRITIONAL COMPOSITION |
JPWO2008105384A1 (en) * | 2007-02-26 | 2010-06-03 | 協和発酵バイオ株式会社 | Citrulline-containing tablets |
EP2116238A4 (en) * | 2007-02-28 | 2014-04-09 | Meiji Co Ltd | Amino acid composition |
JPWO2015137387A1 (en) * | 2014-03-11 | 2017-04-06 | 協和発酵バイオ株式会社 | Muscle enhancer |
CN108697679B (en) * | 2016-02-19 | 2021-08-31 | 株式会社明治 | Amino acid-containing composition |
-
2017
- 2017-07-28 JP JP2017146545A patent/JP2019024389A/en active Pending
-
2018
- 2018-07-27 TW TW107126222A patent/TW201909759A/en unknown
- 2018-07-27 WO PCT/JP2018/028191 patent/WO2019022216A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2019022216A1 (en) | 2019-01-31 |
JP2019024389A (en) | 2019-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100204346A1 (en) | Novel sweetener having sucrose-like taste, method for producing the same, and use of the same | |
JP5876205B2 (en) | Method for improving deficiency of sweetness of D-sorbose in sweetener comprising D-sorbose and improving sweetness persistence | |
US20160367529A1 (en) | Debility preventative | |
JP2013227228A (en) | Muscle increasing agent | |
CN108697679B (en) | Amino acid-containing composition | |
US8921310B2 (en) | Method for accelerating mammalian body fat metabolism | |
WO2009154280A1 (en) | Agent for preventing excessive appetite | |
JP2019077649A (en) | Exercise amount increasing agent and food and drink composition for increasing exercise amount | |
JP2017523183A5 (en) | ||
JP4915959B2 (en) | Novel sweetener with sugar-like taste, production method and use thereof | |
TW201909759A (en) | Amino acid composition for promoting muscle strength | |
TW201909891A (en) | Amino acid composition for promoting noradrenaline secretion | |
JP6646369B2 (en) | Anti-fatigue agent | |
JP7462338B2 (en) | Anti-fatigue | |
JP7083254B2 (en) | Food and beverage composition with reduced bitterness of β-hydroxy-β-methylbutyrate calcium salt (HMBCa) | |
JP2015529470A (en) | Composition containing β-hydroxy-β-methylbutyric acid (METHYLBUTRYICACID) and use thereof | |
JP2013124222A (en) | Visceral fat reducing agent | |
JP6829487B2 (en) | Anti-fatigue | |
WO2023190809A1 (en) | Composition for inhibiting production of cortisol | |
US20230055034A1 (en) | Novel soft candy content and production process thereof | |
JP2022144737A (en) | Composition for preventing increase or decrease of resting energy consumption and composition for preventing decrease or increase of respiratory quotient | |
JP2021093932A (en) | Skin condition improving composition | |
KR20230155258A (en) | Pill Food Composition for Protein Supplement | |
JP5943516B2 (en) | Sweetener for improving biological function comprising D-sorbose as an active ingredient | |
JP2022079610A (en) | Composition for suppressing increase in triglyceride in blood |